PharmaCielo Ltd.
PCLOF
$0.03
-$0.01-17.21%
OTC PK
| 06/30/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 1.90M | 1.19M | 1.19M | 738.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 1.90M | 1.19M | 1.19M | 738.60K |
| Cost of Revenue | -- | 1.89M | 1.71M | 1.71M | 1.91M |
| Gross Profit | -- | 18.30K | -514.60K | -514.60K | -1.17M |
| SG&A Expenses | -- | 4.18M | 4.69M | 4.69M | 5.03M |
| Depreciation & Amortization | -- | 187.00K | 212.70K | 212.70K | 257.20K |
| Other Operating Expenses | -- | -51.10K | -53.80K | -53.80K | -55.20K |
| Total Operating Expenses | -- | 6.20M | 6.56M | 6.56M | 7.13M |
| Operating Income | -- | -4.30M | -5.37M | -5.37M | -6.40M |
| Income Before Tax | -- | -10.31M | -10.43M | -10.43M | -11.22M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -10.31 | -10.43 | -10.43 | -11.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -10.31M | -10.43M | -10.43M | -11.22M |
| EBIT | -- | -4.30M | -5.37M | -5.37M | -6.40M |
| EBITDA | -- | -3.71M | -4.75M | -4.54M | -5.55M |
| EPS Basic | -- | -0.06 | -0.06 | -0.06 | -0.07 |
| Normalized Basic EPS | -- | -0.03 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -- | -0.06 | -0.06 | -0.06 | -0.07 |
| Normalized Diluted EPS | -- | -0.03 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | -- | 667.32M | 667.32M | 667.32M | 654.43M |
| Average Diluted Shares Outstanding | -- | 667.32M | 667.32M | 667.32M | 654.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |